IEX Add to watchlist $222.74 +1.26 (+0.57%) Last updated: Jul 15, 2026 06:04
52-Week Range
$222.74
$157.25 $222.74 $230.18

Fundamentals Overview

IDEX Corporation is near the high of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 32.6 PEG 5.47 P/B 4.09 P/S 4.67

Intrinsic value (DCF)

-5.9% downside vs price

Profitability

Net margin 14.4%

Risk (Beta)

0.97 — in line vol

Earnings & growth

EPS $6.82 Rev -1.4% Profit -6.5% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 60% confidence Risk: Moderate Volatility — Beta 0.97. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · Sentiment improving (1 upgrade)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$16.49B
P/E (TTM)
32.64
EPS (TTM)
$6.82
Dividend Yield
1.29%
52-Week Range
$157.25 - $230.18
Volume vs Avg
N/A
Beta
0.97

About

IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow mon...
Sector: Industrials
Headquarters: US
Employees: 8,700
IPO Date: Jun 1989
Beta: 0.97 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 17, Market Perform: 1, Neutral: 3, Outperform: 9.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $209.50; current price is $222.74. That’s a -5.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 32.64
DCF value (model) $209.50 (-5.9% vs price)
PEG (TTM) 5.47
P/B (TTM) 4.09
P/S (TTM) 4.67
P/FCF (TTM) 26.96
Liquidity & enterprise
Current Ratio (TTM) 3.39
Quick Ratio (TTM) 2.4
Cash Ratio (TTM) 1.16
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 14.38%
Gross margin (TTM) 44.42%
Operating margin (TTM) 20.8%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for IEX.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 17Market Perform 1Neutral 3Outperform 9
1 upgrade, 0 downgrades
Price Target Consensus
Current $222.74
Median $250.00
Consensus $244.71
Low consensus $214.00
High consensus $257.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Oppenheimer maintain Outperform Outperform 2026-06-02
TD Cowen maintain Buy Buy 2026-04-30
Citigroup maintain Buy Buy 2026-04-30
RBC Capital maintain Outperform Outperform 2026-04-30
Stifel maintain Buy Buy 2026-04-14
BMO Capital maintain Market Perform Market Perform 2026-03-27
Argus Research upgrade Hold Buy 2026-02-06
TD Cowen maintain Buy Buy 2026-02-05
RBC Capital maintain Outperform Outperform 2026-02-05
Citigroup maintain Buy Buy 2026-02-05
DA Davidson maintain Neutral Neutral 2026-02-05
Stifel maintain Buy Buy 2026-01-23
Citigroup maintain Buy Buy 2025-12-08
RBC Capital maintain Outperform Outperform 2025-10-30
Stifel maintain Buy Buy 2025-10-20
Oppenheimer maintain Outperform Outperform 2025-10-07
DA Davidson maintain Neutral Neutral 2025-08-04
Stifel maintain Buy Buy 2025-07-31
RBC Capital maintain Outperform Outperform 2025-07-31
Oppenheimer maintain Outperform Outperform 2025-07-31
Stifel maintain Buy Buy 2025-07-21
Citigroup maintain Buy Buy 2025-07-14
Stifel maintain Buy Buy 2025-05-02
RBC Capital maintain Outperform Outperform 2025-05-02
Citigroup maintain Buy Buy 2025-04-14
Stifel maintain Buy Buy 2025-04-14
DA Davidson maintain Neutral Neutral 2025-02-19
RBC Capital maintain Outperform Outperform 2025-02-06
Citigroup maintain Buy Buy 2025-01-13
Stifel maintain Buy Buy 2024-12-11